The Discounted Cash Flow (DCF) valuation of La Jolla Pharmaceutical Co (LJPC) is 12.07 USD. With the latest stock price at 6.22 USD, the upside of La Jolla Pharmaceutical Co based on DCF is 94.1%.
Based on the latest price of 6.22 USD and our DCF valuation, La Jolla Pharmaceutical Co (LJPC) is a buy. buying LJPC stocks now will result in a potential gain of 94.1%.
| Range | Selected | |
| WACC / Discount Rate | 7.2% - 9.7% | 8.5% |
| Long-term Growth Rate | 0.0% - 1.0% | 0.5% |
| Fair Price | 10.36 - 14.75 | 12.07 |
| Upside | 66.5% - 137.1% | 94.1% |